Skip to main content
Clinical Trials/IRCT201201072394N6
IRCT201201072394N6CompletedPhase 3

Effect of vitamin D supplementation on depression severity, inflammatory and oxidative markers in major depressive disorder disorder

Vice-chancellor for research, Tehran University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Willing to participate;
  • Clinical diagnosis of major depressive disorder;
  • A score =15 in the 17-item Hamilton Depression Rating Scale;
  • Age 18 – 65 years;
  • Good health status based on medical history;
  • No antidepressant or dietary supplement use during the previous two months.
  • Exclusion criteria:
  • Substance abuse;
  • Pregnancy and lactation.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice-chancellor for research, Tehran University of Medical Sciences

Similar Trials